Genetic Technologies Limited Appoints Dr. Mervyn Cass as Company Director
October 03 2011 - 10:34AM
Business Wire
The Board of Directors of Genetic Technologies Limited (ASX:
GTG; NASDAQ: GENE) has with great pleasure appointed Dr. Mervyn
Cass as a non-executive Director of the Company.
Dr. Cass is a practicing medical practitioner and, after 28
years as the senior partner in an occupational medical practice in
Port Melbourne, accepted the appointment as Medical Director of a
plastic surgery centre in 1996. He was the founding Chairman of the
Australasian Occupational Medical Group and was a Director of Wolfe
Research Pty. Ltd., a private medical biotech company associated
with RMIT University. He has been an advisor to the Victorian
Government on Workers’ Compensation and Radiological Standards in
general practice. Dr. Cass is currently an executive member of the
Jewish Community Council of Victoria, the roof body of the
Victorian Jewish Community.
The Company’s Chairman Mr. Sid Hack said, “The Directors of
Genetic Technologies are delighted that Mervyn has agreed to join
the Board. His substantial experience in the fields of medicine,
women’s health and restorative surgery will be of great practical
and immediate value in the growth and development of the Company’s
cancer diagnostics business. We very much look forward to working
with Mervyn at this important time in the history of the
Company.”
Genetic Technologies (ASX:GTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Genetic Technologies (ASX:GTG)
Historical Stock Chart
From Jul 2023 to Jul 2024